In a xenograft model of acute lymphoblastic leukemia, CARD11-PIK3R3 expressing anti-CD19 CAR T cells showed superior tumor rejection compared to CAR T cells without the gene fusion, even at low input cell numbers. This evidence concerns the gene PIK3R3 and neoplasm.